JJCO Awards
JJCO Paper of The Year, Highly Commended Paper and Reviewer of the Year
Each year, JJCO awards one of the finest papers selected from the previous year's publication to promote the excellence of research in clinical oncology, and honor outstanding papers published in Japanese Journal of Clinical Oncology. Alongside this, JJCO also presents a Highly Commended Paper and Best Reviewer Award. You can find a list of current and previous award recipients below. Congratulations to all of our winners!
2024 JJCO Paper of the Year
Kenya Kobayashi, Yuki Saito, Hidenori Kage, Osamu Fukuoka, Koji Yamamura, Toshiyuki Mukai, Katsutoshi Oda, Tatsuya Yamasoba
Jpn. J. Clin. Oncol. (2023) 53 (9): 798-807
2024 JJCO Highly Commended Paper
Mariko Hanafusa, Yuri Ito, Hironori Ishibashi, Tomoki Nakaya, Nobutoshi Nawa, Tomotaka Sobue, Kenichi Okubo, Takeo Fujiwara
Jpn. J. Clin. Oncol. (2023) 53 (4): 287-296
2024 JJCO Best Reviewer Award
Dr. Taketo Kawai
(Department of Urology, International University of Health and Welfare Ichikawa Hospital)
2023 JJCO Paper of the Year
Research policy in supportive care and palliative care for cancer dyspnea
Yoshinobu Matsuda, Takashi Yamaguchi, Yoshihisa Matsumoto, Hiroto Ishiki, Yuko Usui, Jun Kako, Kozue Suzuki, Ryo Matsunuma, Masanori Mori, Hiroaki Watanabe, Sadamoto Zenda
Jpn. J. Clin. Oncol. (2022) 52 (3): 260-265
2023 JJCO Highly Commended Paper
Nobuaki Azemoto, Makoto Ueno, Hiroaki Yanagimoto, Nobumasa Mizuno, Yasuyuki Kawamoto, Yuta Maruki, Kazuo Watanabe, Rei Suzuki, Junichi Kaneko, Yuya Hisada, Hiroki Sato, Satoshi Kobayashi, Hideki Miyata, Masayuki Furukawa, Takuro Mizukami, Haruo Miwa, Yoshinori Ohno, Kunihiro Tsuji, Akiko Tsujimoto, Hiroaki Nagano, Hiroyuki Okuyama, Akinori Asagi, Naohiro Okano, Hiroshi Ishii, Chigusa Morizane, Masafumi Ikeda, Junji Furuse on behalf of the Japan Observational Study Committee of Hepatobiliary and Pancreatic Oncology (JOSC-HBP)
Jpn. J. Clin. Oncol. (2022) 52 (2): 134-142
2023 JJCO Best Reviewer Award
Dr. Kazuhiro Sentani
(Graduate School of Biomedical and Health Sciences, Hiroshima University)
2022 JJCO Paper of the Year
Yusuke Tabei, Keiichi Kobayashi, Kuniaki Saito, Saki Shimizu, Kaori Suzuki, Nobuyoshi Sasaki, Yoshiaki Shiokawa, Motoo Nagane
Jpn. J. Clin. Oncol. (2021) 51 (1): 45–53
2022 JJCO Highly Commended Paper
Saki Harashima, Maiko Fujimori, Tatsuo Akechi, Tomohiro Matsuda, Kumiko Saika, Takaaki Hasegawa, Keisuke Inoue, Kazuhiro Yoshiuchi, Isao Miyashiro, Yosuke Uchitomi, Yutaka J Matsuoka
Jpn. J. Clin. Oncol. (2021) 51 (5): 744-752
2022 JJCO Best Reviewer Award
Prof. Katsuyuki Hotta, Okayama University Hospital
2021 JJCO Paper of the Year
Regulatory changes after the enforcement of the new Clinical Trials Act in Japan
Kenichi Nakamura, Taro Shibata
Jpn. J. Clin. Oncol. (2020) 50 (4): 399–404
2021 JJCO Highly Commended Paper
Yasutaka Kimura, Miki Hosoya, Kyoko Toju, Chikako Shimizu, Tatsuya Morita
Jpn. J. Clin. Oncol. (2020) 50 (12): 1426–1433
2021 JJCO Best Reviewer Award
Dr. Satoru Taguchi, Kyorin University & The University of Tokyo
2020 JJCO Paper of the Year
Takeshi Nawa, Keisuke Fukui, Tomio Nakayama, Motoyasu Sagawa, Tohru Nakagawa, Hideo Ichimura, Tetsuya Mizoue
Jpn. J. Clin. Oncol. (2019) 49 (2): 130–136.
2020 JJCO Best Reviewer Award
Dr Eiji Kikuchi, St. Marianna University School of Medicine, and Dr Maiko Fujimori, National Cancer Center Japan, Center for Public Health Sciences
2019 JJCO Paper of the Year
Kenji Sekiguchi, Keiko Akahane, Mami Ogita, Chiori Haga, Ryoko Ito, Satoru Arai, Yasushi Ishida, Yoichiro Tsukada, Jiro Kawamori
Jpn. J. Clin. Oncol. (2018) 48 (5): 450–457.
2019 JJCO Highly Commended Paper
Yasushi Ishida, Miho Maeda, Souichi Adachi, Takeshi Rikiishi, Maho Sato, Hiroshi Kawaguchi, Atsushi Manabe, Mika Tokuyama, Hiroki Hori, Jun Okamura, Atsushi Ogawa, Hiroaki Goto, Ryoji Kobayashi, Shinji Yoshinaga, Junichiro Fujimoto, Tatsuo Kuroda
Jpn. J. Clin. Oncol. (2018) 48 (9): 806–814.
2019 JJCO Best Reviewer Award
Dr. Tsunenori Kondo, Tokyo Women’s Medical University
2018 JJCO Paper of the Year
Prevalence of Lynch syndrome and Lynch-like syndrome among patients with colorectal cancer in a Japanese hospital-based population
Noriyasu Chika, Hidetaka Eguchi, Kensuke Kumamoto, Okihide Suzuki, Keiichiro Ishibashi, Tetsuhiko Tachikawa, Kiwamu Akagi, Jun-ichi Tamaru, Yasushi Okazaki, and Hideyuki Ishida
Jpn. J. Clin. Oncol. (2017) 47 (2): 108-117.
2018 JJCO Highly Commended Paper
Surgical outcomes of robot-assisted rectal cancer surgery using the da Vinci Surgical System: a multi-center pilot Phase II study
Shunsuke Tsukamoto, Yuji Nishizawa, Hiroki Ochiai, Yuichiro Tsukada, Takeshi Sasaki, Dai Shida, Masaaki Ito, and Yukihide Kanemitsu
Jpn. J. Clin. Oncol. (2017) 47 (12): 1135-1140.
2017 JJCO Paper of the Year
Secondhand smoke exposure and risk of lung cancer in Japan: a systematic review and meta-analysis of epidemiologic studies
Megumi Hori, Hirokazu Tanaka, Kenji Wakai, Shizuka Sasazuki, and Kota Katanoda
Jpn. J. Clin. Oncol. (2016) 46 (10): 942-951.
2017 JJCO Highly Commended Paper
Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data
Masau Sekiguchi, Ataru Igarashi, Takahisa Matsuda, Minori Matsumoto, Taku Sakamoto, Takeshi Nakajima, Yasuo Kakugawa, Seiichiro Yamamoto, Hiroshi Saito, and Yutaka Saito
Jpn. J. Clin. Oncol. (2016) 46 (2): 650-656.
2016 JJCO Paper of the Year
Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304)
Kazuhiro Tanaka, Junki Mizusawa, Haruhiko Fukuda, Nobuhito Araki, Hirokazu Chuman, Mitsuru Takahashi, Toshifumi Ozaki, Toru Hiruma, Hiroyuki Tsuchiya, Hideo Morioka, Hiroshi Hatano, and Yukihide Iwamoto
Jpn. J. Clin. Oncol. (2015) 45 (6): 555-561.
2016 JJCO Highly Commended Paper
Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: a randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902)
Hidetoshi Katsuno, Koutarou Maeda, Takashi Kaiho, Katsuyuki Kunieda, Kimihiko Funahashi, Junichi Sakamoto, Toru Kono, Hirotoshi Hasegawa, Yoshiyuki Furukawa, Yoshihiro Imazu, Satoshi Morita, and Masahiko Watanabe
Jpn. J. Clin. Oncol. (2015) 45 (7): 650-656.
2015 JJCO Paper of the Year
General Health Status and Late Effects Among Adolescent and Young Adult Survivors of Childhood Cancer in Japan
Shuichi Ozono, Yasushi Ishida, Misato Honda, Jun Okamura, Keiko Asami, Naoko Maeda, Naoko Sakamoto, Hiroko Inada, Tsuyako Iwai, Kiyoko Kamibeppu, Naoko Kakee, and Keizo Horibe
Jpn. J. Clin. Oncol. (2014) 44 (10): 932-940.
2015 JJCO Highly Commended Paper
Quality Control by Photo Documentation for Evaluation of Laparoscopic and Open Colectomy with D3 Resection for Stage II/III Colorectal Cancer: Japan Clinical Oncology Group Study JCOG 0404
Kentaro Nakajima, Masafumi Inomata, Tomonori Akagi, Tsuyoshi Etoh, Kenichi Sugihara, Masahiko Watanabe, Seiichiro Yamamoto, Hiroshi Katayama, Yoshihiro Moriya, and Seigo Kitano
Jpn. J. Clin. Oncol. (2014) 44 (9): 799-806.
2014 JJCO Paper of the Year
Short Hydration in Chemotherapy Containing Cisplatin (≥75 mg/m 2 ) for Patients with Lung Cancer: A Prospective Study
Hidehito Horinouchi, Kaoru Kubota, Hidetoshi Itani, Tomoko Katsui Taniyama, Shinji Nakamichi, Hiroshi Wakui, Shintaro Kanda, Hiroshi Nokihara, Noboru Yamamoto, Ikuo Sekine, and Tomohide Tamura
Jpn. J. Clin. Oncol. (2013) 43 (11): 1105–1109
2014 JJCO Highly Commended Paper
An Updated Report of the Trends in Cancer Incidence and Mortality in Japan
Kota Katanoda, Tomohiro Matsuda, Ayako Matsuda, Akiko Shibata, Yoshikazu Nishino, Manabu Fujita, Midori Soda, Akiko Ioka, Tomotaka Sobue, and Hiroshi Nishimoto
Jpn. J. Clin. Oncol. (2013) 43 (5): 492-507
2013 JJCO Paper of the Year
Clinical Outcome of Japanese Metastatic Colorectal Cancer Patients Harbouring the KRAS p.G13D Mutation Treated with Cetuximab + Irinotecan
Hideaki Bando, Takayuki Yoshino, Satoshi Yuki, Eiji Shinozaki, Tomohiro Nishina, Shigenori Kadowaki, Kentaro Yamazaki, Shinya Kajiura, Katsuya Tsuchihara, Satoshi Fujii, Takeharu Yamanaka, and Atsushi Ohtsu
Jpn. J. Clin. Oncol. (2012) 42 (12): 1146-1151
2013 JJCO Highly Commended Paper
Gender Difference in Hematological Toxicity Among Lung Cancer Patients Receiving Amrubicin Monotherapy
Reiko Ando Makihara, Yoshinori Makino, Noboru Yamamoto, Nobuaki Yokote, Hiroshi Nokihara, Ikuo Sekine, Yuichiro Ohe, Tomohide Tamura, and Hiroshi Yamamoto
Jpn. J. Clin. Oncol. (2012) 42 (12): 1187–1191
2012 JJCO Paper of the Year
Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer
Hiroji Iwata, Nobuaki Sato, Norikazu Masuda, Seigo Nakamura, Naohito Yamamoto, Katsumasa Kuroi, Masafumi Kurosumi, Hitoshi Tsuda, Futoshi Akiyama, Yasuo Ohashi, and Masakazu Toi
Jpn. J. Clin. Oncol. (2011) 41(7): 867-875
2011 JJCO Paper of the Year
Usefulness of Narrow-band Imaging for Detecting the Primary Tumor Site in Patients with Primary Unknown Cervical Lymph Node Metastasis
Tomomasa Hayashi, Manabu Muto, Ryuichi Hayashi, Keiko Minashi, Tomonori Yano, Seiji Kishimoto, and Satoshi Ebihara
Jpn. J. Clin. Oncol. (2010) 40(6): 537-541
2010 JJCO Paper of the Year
Fusion of MRI and Sonography Image for Breast Cancer Evaluation Using Real-time Virtual Sonography with Magnetic Navigation: First Experience
Shogo Nakano, Miwa Yoshida, Kimihito Fujii, Kyoko Yorozuya, Yukako Mouri, Junko Kousaka, Takashi Fukutomi, Junko Kimura, Tsuneo Ishiguchi, Kazuko Ohno, Takao Mizumoto, and Michiko Harao
Jpn. J. Clin. Oncol. (2009) 39 (9): 552-559
2009 JJCO Paper of the Year
Multi-Center Phase II Study for Combination Therapy with Paclitaxel/Doxifluridine to Treat Advanced/Recurrent Gastric Cancer Showing Resistance to S-1 (OGSG 0302)
Hiroya Takiuchi, Masahiro Goto, Hiroshi Imamura, Hiroshi Furukawa, Motohiro Imano, Haruhiko Imamoto, Yutaka Kimura, Hideyuki Ishida, Kazumasa Fujitani, Hiroyuki Narahara, and Toshio Shimokawa
Jpn. J. Clin. Oncol. (2008) 38(3): 176-181
2008 JJCO Paper of the Year
Molecular Markers and Changes of Computed Tomography Appearance in Lung Adenocarcinoma with Ground-glass Opacity
Yukihiro Yoshida, Akiko Kokubu, Kenji Suzuki, Hidehiko Kuribayashi, Koji Tsuta, Yoshihiro Matsuno, Masahiko Kusumoto, Yae Kanai, Hisao Asamura, Setsuo Hirohashi, and Tatsuhiro Shibata
Jpn. J. Clin. Oncol. (2007) 37(12): 907-912
2007 JJCO Paper of the Year
Adjuvant Chemotherapy with Uracil–Tegafur for Pathological Stage III Rectal Cancer after Mesorectal Excision with Selective Lateral Pelvic Lymphadenectomy: A Multicenter Randomized Controlled Trial
Takayuki Akasu, Yoshihiro Moriya, Yasuo Ohashi, Shigeaki Yoshida, Kuniaki Shirao, and Susumu Kodaira
Jpn. J. Clin. Oncol. (April 2006) 36(4): 237-244
2006 JJCO Paper of the Year
Clinical Impact of Criteria for Complete Response (CR) of Primary Site to Treatment of Esophageal Cancer
Makoto Tahara, Atsushi Ohtsu, Shuichi Hironaka, Narikazu Boku, Satoshi Ishikura, Yoshinori Miyata, Takashi Ogino, and Shigeaki Yoshida
Jpn. J. Clin. Oncol. (June 2005) 35(6): 316-323
2005 JJCO Paper of the Year
Cancer Mortality Among Japanese Immigrants and their Descendants in the State of São Paulo, Brazil, 1999–2001
Motoki Iwasaki, Cecilia Polidoro Mameri, Gerson Shigueaki Hamada, and Shoichiro Tsugane
Jpn. J. Clin. Oncol. (2004) 34(11): 673-680
